Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NanoKTN Supports Regenerative Medicine Development

Published: Wednesday, May 08, 2013
Last Updated: Wednesday, May 08, 2013
Bookmark and Share
UK Regenerative Medicine Platform (UKRMP) Safety Hub announced.

The Nanotechnology Knowledge Transfer Network (NanoKTN) has announced its support to a consortium led by the MRC Centre for Drug Safety Science, University of Liverpool, which has been awarded £4.5M for a UK Regenerative Medicine Platform (UKRMP) Safety Hub.
 
The Hub aims to develop methods to monitor the biodistribution and behaviour of transplanted cells in well-characterised disease models, using innovative nanochemistry and molecular imaging, and brings together experts in nanochemistry, imaging, stem cell biology and safety science, to enable clinical translation of safe, effective regenerative medicine therapies.
 
Following the successful launch of the UKRMP Safety Hub, the NanoKTN will now be supporting them with future networking activities and events to help to disseminate the outcomes from their work and to increase links to the business community.
 
The NanoKTN supports the transfer of knowledge and experience between key research organisations, in order to develop new strategies and clinical imaging protocols necessary for effective safety assessment of regenerative medicine therapies. These developments are imperative to enable the clinical adoption of such therapies and to ensure that the UK realises its potential as its regenerative medicine industry develops.
 
Dr Felicity Sartain, Theme Manager - Healthcare and Life Sciences at the NanoKTN explains, “One of the key areas within the NanoKTN’s Healthcare and Life Sciences theme is nanomedicine, and this application can only be successfully developed into treatments if clinicians and healthcare professionals engage with the life science industry. The NanoKTN will be working with the University of Liverpool to disseminate information and outcomes from the UKRMP Safety Hub, through networking activities, co-organised events and providing representation on the steering committee.”
 
Dr Sartain continues, “The link between academic research and industry is already close in the life sciences industries and we are looking forward to bringing these communities even closer together to help the UKRMP Safety Hub develop its plans and help to identify companies for future collaboration through our industry network of UK members.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NanoKTN Announces Start of UK NanoRegen Mission to Germany and Austria
Raising the profile of UK nanotechnology capabilities in regenerative medicine.
Thursday, September 06, 2012
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Mutated Mitochondria Found in Stem Cells
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!